Stephanie McCall
Gerontology · Laurens, SCNPI 1598327496
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 98 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 12.4% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $604, 2.6 times the $229 reported in 2021.
Across 98 payments — averaging $16.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$205
- AstraZeneca$184
- Novo Nordisk$173
- Otsuka America Pharmaceutical, Inc.$128
- Supernus Pharmaceuticals, Inc.$105
- Novartis$95
- plus $761 from 28 others
What the payments were for
- Food & beverage$1,650100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,650 in reported general payments places this provider in the 65th percentile of 137 gerontology providers in South Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 59 | $64,572 |
| WegovySemaglutide | 19 | $37,415 |
| TrulicityDulaglutide | 33 | $35,979 |
| JardianceEmpagliflozin | 21 | $29,516 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 28 | $17,671 |
| Tresiba Flextouch U-100Insulin Degludec | 17 | $11,469 |
| EliquisApixaban | 11 | $10,723 |
| Gabapentin | 131 | $1,909 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 60 | $1,710 |
| Atorvastatin Calcium | 133 | $1,292 |
| Estradiol (Once Weekly)Estradiol | 12 | $1,291 |
| Omeprazole | 106 | $1,235 |
| Losartan Potassium | 145 | $1,183 |
| Hydroxyzine Hcl | 27 | $1,059 |
| Levothyroxine Sodium | 97 | $891 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Wegovy | $173 | $101,98778 claims |
| Lilly USA, LLCTrulicity | $45 | $35,97933 claims |
| Boehringer IngelheimJardiance | $25 | $29,51621 claims |
| GSKTrelegy Ellipta | $205 | $17,67128 claims |
| PfizerEliquis | $13 | $10,72311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 137 gerontology providers in South Carolina.
Other gerontology in Laurens
- Timothy MalinowskiGreenville$49K
- Ann ShattuckNorth Charleston$15K
- Erin SullivanColumbia$13K
- Nicole FerroniCharleston$11K
- Kathryn RarickGreenville$10K
- Ryan BakerColumbia$9K
- Rachael WillsGreenville$8K
- Karen CainGreenville$8K
- Emily KachelmeyerSummerville$7K
- Elizabeth GreeneSpartanburg$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.